Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B F Holmes

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biopharmaceutics & Drug Disposition|July 1, 1983
Pharmacokinetic studies with atenolol in the dogJ McAinsh, B F Holmes
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 25, 2000
Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activatedW W Winder, B F Holmes
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 24, 1999
Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscleB F Holmes, E J Kurth-Kraczek, W W Winder
Biopharmaceutics & Drug Disposition|April 1, 1981
Bioavailability of propranolol and bendrofluazide formulationsJ McAinsh, B F Holmes, N S Baber, et al.
Clinical Pharmacology and Therapeutics|September 1, 1980
Atenolol kinetics in renal failureJ McAinsh, B F Holmes, S Smith, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1990
The metabolic disposition of an orally active pyridyl thiadiazinone cardiotonic agent (MPTD) in rat and baboonD McKillop, K J Pickup, A J Swaisland, et al.
Biopharmaceutics & Drug Disposition|October 1, 1980
Bioavailability of atenolol formulationsJ Mcainsh, W T Simpson, B F Holmes, et al.
Biopharmaceutics & Drug Disposition|January 1, 1981
Bioavailability of sustained release propranolol formulationsJ McAinsh, N S Baber, B F Holmes, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 14, 2000
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscleW W Winder, B F Holmes, D S Rubink, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biopharmaceutics & Drug Disposition|July 1, 1983
Pharmacokinetic studies with atenolol in the dogJ McAinsh, B F Holmes
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 25, 2000
Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activatedW W Winder, B F Holmes
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 24, 1999
Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscleB F Holmes, E J Kurth-Kraczek, W W Winder
Biopharmaceutics & Drug Disposition|April 1, 1981
Bioavailability of propranolol and bendrofluazide formulationsJ McAinsh, B F Holmes, N S Baber, et al.
Clinical Pharmacology and Therapeutics|September 1, 1980
Atenolol kinetics in renal failureJ McAinsh, B F Holmes, S Smith, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1990
The metabolic disposition of an orally active pyridyl thiadiazinone cardiotonic agent (MPTD) in rat and baboonD McKillop, K J Pickup, A J Swaisland, et al.
Biopharmaceutics & Drug Disposition|October 1, 1980
Bioavailability of atenolol formulationsJ Mcainsh, W T Simpson, B F Holmes, et al.
Biopharmaceutics & Drug Disposition|January 1, 1981
Bioavailability of sustained release propranolol formulationsJ McAinsh, N S Baber, B F Holmes, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 14, 2000
Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscleW W Winder, B F Holmes, D S Rubink, et al.
Pageof 1